Cargando…

Alpha-1 Antitrypsin Deficiency: Home Therapy

While available in only a few countries, home therapy is a possible strategy for the treatment of alpha-1 antitrypsin deficiency. We want to describe our experience in the management of human alpha-1 antitrypsin using home care intravenous augmentation therapy during this emergency period caused by...

Descripción completa

Detalles Bibliográficos
Autores principales: Annunziata, Anna, Lanza, Maurizia, Coppola, Antonietta, Andreozzi, Paolo, Spinelli, Sara, Fiorentino, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082418/
https://www.ncbi.nlm.nih.gov/pubmed/33935692
http://dx.doi.org/10.3389/fphar.2021.575402
_version_ 1783685839012757504
author Annunziata, Anna
Lanza, Maurizia
Coppola, Antonietta
Andreozzi, Paolo
Spinelli, Sara
Fiorentino, Giuseppe
author_facet Annunziata, Anna
Lanza, Maurizia
Coppola, Antonietta
Andreozzi, Paolo
Spinelli, Sara
Fiorentino, Giuseppe
author_sort Annunziata, Anna
collection PubMed
description While available in only a few countries, home therapy is a possible strategy for the treatment of alpha-1 antitrypsin deficiency. We want to describe our experience in the management of human alpha-1 antitrypsin using home care intravenous augmentation therapy during this emergency period caused by SARS-CoV2 infection. We assessed the safety of the home treatment and the quality of life of patients enrolled in the program.
format Online
Article
Text
id pubmed-8082418
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80824182021-04-30 Alpha-1 Antitrypsin Deficiency: Home Therapy Annunziata, Anna Lanza, Maurizia Coppola, Antonietta Andreozzi, Paolo Spinelli, Sara Fiorentino, Giuseppe Front Pharmacol Pharmacology While available in only a few countries, home therapy is a possible strategy for the treatment of alpha-1 antitrypsin deficiency. We want to describe our experience in the management of human alpha-1 antitrypsin using home care intravenous augmentation therapy during this emergency period caused by SARS-CoV2 infection. We assessed the safety of the home treatment and the quality of life of patients enrolled in the program. Frontiers Media S.A. 2021-04-15 /pmc/articles/PMC8082418/ /pubmed/33935692 http://dx.doi.org/10.3389/fphar.2021.575402 Text en Copyright © 2021 Annunziata, Lanza, Coppola, Andreozzi, Spinelli and Fiorentino. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Annunziata, Anna
Lanza, Maurizia
Coppola, Antonietta
Andreozzi, Paolo
Spinelli, Sara
Fiorentino, Giuseppe
Alpha-1 Antitrypsin Deficiency: Home Therapy
title Alpha-1 Antitrypsin Deficiency: Home Therapy
title_full Alpha-1 Antitrypsin Deficiency: Home Therapy
title_fullStr Alpha-1 Antitrypsin Deficiency: Home Therapy
title_full_unstemmed Alpha-1 Antitrypsin Deficiency: Home Therapy
title_short Alpha-1 Antitrypsin Deficiency: Home Therapy
title_sort alpha-1 antitrypsin deficiency: home therapy
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082418/
https://www.ncbi.nlm.nih.gov/pubmed/33935692
http://dx.doi.org/10.3389/fphar.2021.575402
work_keys_str_mv AT annunziataanna alpha1antitrypsindeficiencyhometherapy
AT lanzamaurizia alpha1antitrypsindeficiencyhometherapy
AT coppolaantonietta alpha1antitrypsindeficiencyhometherapy
AT andreozzipaolo alpha1antitrypsindeficiencyhometherapy
AT spinellisara alpha1antitrypsindeficiencyhometherapy
AT fiorentinogiuseppe alpha1antitrypsindeficiencyhometherapy